Recombinant Mouse Osteopontin (OPN)

• Supplier: R&D Systems
• Catalog: 441-OP-050
• Category: Protein
• Nature: Recombinant
• Source: Mouse myeloma cell line, NS0-derived, Leu17-Asn294 (Glu99Gly), with a C-terminal 6-His tag
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• SwissProt/Accession: Q547B5
• Gene: SPP1

Product References

Osteopontin induces growth of metastatic tumors in a preclinical model of - Osteopontin induces growth of metastatic tumors in a preclinical model of

Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, Simmons BH, Wu A, Lee JH, Bergqvist S, Kraynov E. J Exp Clin Cancer Res. 2012 Mar 23;31:26.

Osteopontin-stimulated expression of matrix metalloproteinase-9 causes - Osteopontin-stimulated expression of matrix metalloproteinase-9 causes

Dahiya S, Givvimani S, Bhatnagar S, Qipshidze N, Tyagi SC, Kumar A. J Immunol. 2011 Sep 1;187(5):2723-31.

Adenosine and osteopontin contribute to the development of chronic obstructive - Adenosine and osteopontin contribute to the development of chronic obstructive

Schneider DJ, Lindsay JC, Zhou Y, Molina JG, Blackburn MR. FASEB J. 2010 Jan;24(1):70-80.

In vivo osteopontin-induced macrophage accumulation is dependent on CD44 - In vivo osteopontin-induced macrophage accumulation is dependent on CD44

Marcondes MC, Poling M, Watry DD, Hall D, Fox HS. Cell Immunol. 2008;254(1):56-62.

Osteopontin has a crucial role in allergic airway disease through regulation of - Osteopontin has a crucial role in allergic airway disease through regulation of

Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, Lambrecht BN, Lloyd CM, Panoutsakopoulou V. Nat Med. 2007 May;13(5):570-8. Epub 2007 Apr 15.

Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage - Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage

Jacobs JP, Pettit AR, Shinohara ML, Jansson M, Cantor H, Gravallese EM, Mathis D, Benoist C. Arthritis Rheum. 2004 Aug;50(8):2685-94.

Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated - Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated

Bruemmer D, Collins AR, Noh G, Wang W, Territo M, Arias-Magallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, Law RE, Hsueh WA. J Clin Invest. 2003 Nov;112(9):1318-31.